Table 2.
The disease-free survival (DFS) was assessed by Kaplan-Meier univariate analysis.
| Variables | Cases (N) | 5-year DFS rate (%) | Mean DFS survival (months) | P# |
|---|---|---|---|---|
| Age (year) | 0.212 | |||
| <47 | 72 | 62.2% | 61.6±3.9 | |
| ≥47 | 56 | 38.2% | 55.5±3.2 | |
| HPV infection | 0.293 | |||
| Negative | 18 | 73.1% | 64.5±6.1 | |
| Positive | 110 | 43.2% | 56.9±2.7 | |
| FIGO stage | 0.001* | |||
| I–II | 73 | 56.7% | 63.5±2.8 | |
| III | 55 | 30.1% | 46.1±3.6 | |
| Horizontal diffusion diameter | 0.029* | |||
| <4.0 cm | 78 | 53.3% | 63.0±2.8 | |
| ≥4.0 cm | 50 | 40.5% | 49.6±4.2 | |
| Stromal invasion depth | 0.011* | |||
| <2/3 | 59 | 63.3% | 64.6±3.4 | |
| ≥2/3 | 69 | 33.1% | 51.5±3.3 | |
| Vagina invasion | 0.137 | |||
| Negative | 103 | 44.3% | 56.1±2.8 | |
| Positive | 25 | 66.3% | 65.6±5.3 | |
| Parametrial invasion | 0.001* | |||
| Negative | 77 | 60.1% | 63.3±3.0 | |
| Positive | 51 | 20.5% | 46.7±3.3 | |
| Lymphovascular invasion | <0.001* | |||
| Negative | 81 | 57.4% | 64.1±2.7 | |
| Positive | 47 | 20.0% | 41.9±3.9 | |
| Pelvic lymph node metastasis | <0.001* | |||
| Poor | 81 | 66.2% | 65.0±3.0 | |
| Positive | 47 | 10.5% | 44.0±2.8 | |
| USP8 expression | 0.003* | |||
| Low | 48 | 68.3% | 67.9±3.4 | |
| High | 80 | 34.4% | 51.6±3.3 |
#
P value was analyzed by log-rank test;
*
indicates P<0.05 with statistical significance.